IL13 (Tralokinumab Biosimilar) antibody
Reactivity: Human
FACS
Host: Human
Monoclonal
unconjugated
-
- Target See all IL13 (Tralokinumab Biosimilar) products
- IL13 (Tralokinumab Biosimilar)
- Reactivity
- Human
-
Host
-
Human
-
Clonality
- Monoclonal
-
Conjugate
- This IL13 (Tralokinumab Biosimilar) antibody is un-conjugated
- Application
- Flow Cytometry (FACS)
- Purpose
- Anti-IL13 (Tralokinumab biosimilar) mAb
- Characteristics
- Biosimilar reference antibodies
- Purification
- Purified from cell culture supernatant by affinity chromatography
- Isotype
- IgG4
-
-
- Application Notes
- Flow Cyt 1:100
- Comment
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C,-80 °C
- Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
- Target
- IL13 (Tralokinumab Biosimilar)
- Abstract
- IL13 (Tralokinumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- Interleukin-13, IL-13
- UniProt
- P35225
-
You are here:
